120 related articles for article (PubMed ID: 12871500)
1. The ionic contrast medium ioxaglate interferes with thrombin-mediated feedback activation of factor V, factor VIII and platelets.
Al Dieri R; Béguin S; Hemker HC
J Thromb Haemost; 2003 Feb; 1(2):269-74. PubMed ID: 12871500
[TBL] [Abstract][Full Text] [Related]
2. Iohexol, platelet activation and thrombosis. II. Iohexol-induced platelet secretion does not affect collagen-induced or tissue-factor-induced thrombus formation in blood that is anticoagulated with heparin and aspirin.
Sakariassen KS; Buchmann M; Hamers MJ; Stormorken H
Acta Radiol; 1998 Jul; 39(4):355-61. PubMed ID: 9685818
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the iodinated contrast agents Ioxaglate, Iohexol and Iodixanol on thrombus formation and fibrinolysis.
Jones CI; Goodall AH
Thromb Res; 2003; 112(1-2):65-71. PubMed ID: 15013276
[TBL] [Abstract][Full Text] [Related]
4. Differences between contrast media in the inhibition of platelet activation by specific platelet agonists.
Li X; Gabriel DA
Acad Radiol; 1997 Feb; 4(2):108-14. PubMed ID: 9061083
[TBL] [Abstract][Full Text] [Related]
5. Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab.
Dangas G; Badimon JJ; Coller BS; Fallon JT; Sharma SK; Hayes RM; Meraj P; Ambrose JA; Marmur JD
Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1342-9. PubMed ID: 9714143
[TBL] [Abstract][Full Text] [Related]
6. Abciximab inhibits procoagulant activity but not the release reaction upon collagen- or clot-adherent platelets.
Ilveskero S; Lassila R
J Thromb Haemost; 2003 Apr; 1(4):805-13. PubMed ID: 12871419
[TBL] [Abstract][Full Text] [Related]
7. Effects of radiographic contrast agents on thrombin formation and activity.
Fay WP; Parker AC
Thromb Haemost; 1998 Aug; 80(2):266-72. PubMed ID: 9716151
[TBL] [Abstract][Full Text] [Related]
8. Effect of abciximab on prothrombin activation and thrombin generation in patients with acute myocardial infarction also receiving reteplase.
Merlini PA; Repetto A; Andreoli AM; Ricci S; Lombardi A; Finardi A; Dipasquale G; Lamponi M; Mannucci PM; Ardissino D
Am J Cardiol; 2004 Jan; 93(2):195-8. PubMed ID: 14715345
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III.
Baruch D; Lindhout T; Wagenvoord R; Hemker HC
Haemostasis; 1986; 16(2):71-81. PubMed ID: 3086193
[TBL] [Abstract][Full Text] [Related]
10. Effects of the glycoprotein IIb/IIIa receptor antagonist c7E3 Fab and anticoagulants on platelet aggregation and thrombin potential under high coagulant challenge in vitro.
Koestenberger M; Gallistl S; Cvirn G; Roschitz B; Muntean W
Blood Coagul Fibrinolysis; 2000 Jul; 11(5):425-32. PubMed ID: 10937803
[TBL] [Abstract][Full Text] [Related]
11. An ionic contrast agent inhibits platelet-dependent thrombin generation and boosts the effect of abciximab.
Al Dieri R; de Muinck E; Hemker HC; Béguin S
Thromb Haemost; 2001 May; 85(5):944-5. PubMed ID: 11372697
[No Abstract] [Full Text] [Related]
12. GPIIb-IIIa antagonist-induced reduction in platelet surface factor V/Va binding and phosphatidylserine expression in whole blood.
Furman MI; Krueger LA; Frelinger AL; Barnard MR; Mascelli MA; Nakada MT; Michelson AD
Thromb Haemost; 2000 Sep; 84(3):492-8. PubMed ID: 11019977
[TBL] [Abstract][Full Text] [Related]
13. Laboratory monitoring of heparin and the combination of heparin and the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) in patients undergoing percutaneous transluminal coronary angioplasty (PTCA).
Zahn R; Haubelt H; Bechtloff S; Schneider S; Frilling B; Rustige J; Marsalek P; Seidl K; Senges J; Hellstern P
Herz; 2003 Aug; 28(5):445-52. PubMed ID: 12928744
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: potential contributing mechanism of benefit in acute coronary syndromes.
Li Y; Spencer FA; Ball S; Becker RC
J Thromb Thrombolysis; 2000 Aug; 10(1):69-76. PubMed ID: 10947916
[TBL] [Abstract][Full Text] [Related]
15. Effects of ionic and nonionic contrast media on endothelium and on arterial thrombus formation.
Barstad RM; Buchmann MS; Hamers MJ; Orning L; Orvim U; Stormorken H; Sakariassen KS
Acta Radiol; 1996 Nov; 37(6):954-61. PubMed ID: 8995473
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the enzymatic activity of alpha-thrombin by polyanions: consequences on intrinsic activation of factor V and factor VIII.
Ofosu FA
Haemostasis; 1991; 21(4):240-7. PubMed ID: 1794749
[TBL] [Abstract][Full Text] [Related]
17. [Suppressive effects of iodinated contrast media on human platelet aggregation].
Tamura A; Ohata C; Hirakakiuchi Y; Sato T
Yakugaku Zasshi; 1995 Mar; 115(3):250-5. PubMed ID: 7738783
[TBL] [Abstract][Full Text] [Related]
18. [Different inhibiting effects of abciximab and tirofiban on platelet thrombus formation on a collagen surface under flow conditions].
Shimazaki T; Goto S; Sakakibara M; Eto K; Kim JY; Ichikawa N; Yoshida M; Nagaoka Y; Isshiki T; Handa S
J Cardiol; 2000 Aug; 36(2):113-21. PubMed ID: 10955255
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation.
Kanemitsu S; Nishikawa M; Onoda K; Shimono T; Shimpo H; Yazaki A; Tanaka K; Shiku H; Yada I
J Thorac Cardiovasc Surg; 2003 Aug; 126(2):428-35. PubMed ID: 12928640
[TBL] [Abstract][Full Text] [Related]
20. The assessment of thrombotic markers utilizing ionic versus non-ionic contrast during coronary angiography and intervention trial.
Shah B; Berger JS; Allen N; Guo Y; Sedlis SP; Xu J; Perez A; Attubato M; Slater J; Feit F
Catheter Cardiovasc Interv; 2016 Nov; 88(5):727-737. PubMed ID: 26773574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
